Meyka AI API is live for developers.Start building.
Advertisement
Landec Corporation

Landec Corporation (LNDC) Stock Overview

Explore Landec Corporation’s financial performance, market position, analyst ratings, and future outlook.

LNDCNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$8.76
$0.32(3.52%)
U.S. Market opens in 54h 39m
Advertisement

Landec Corporation (LNDC)

Meyka AI Score

Z

Key Financials

Market Cap263.6M
P/E Ratio-10.51
EPS (TTM)$-2.17
ROE-9.05%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$6.92

LNDC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Landec Corporation (LNDC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $6.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.51 and a market capitalization of 263.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
22.69%
3-Month Change
-3.52%
6-Month Change
-21.99%
Year-to-Date (YTD) Change
N/A
1-Year Change
-23.96%
3-Year Change
-22.68%
5-Year Change
-33.38%
All-Time (Max) Change
-31.29%

Contact Information

16503061650
5201 Great America Pkwy Ste 232, Santa Clara, CA, 93455

Company Facts

6,890 Employees
IPO DateFeb 16, 1996
CountryUS

Frequently Asked Questions